Skip to main content

Peer Review reports

From: Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study

Original Submission
18 Oct 2010 Submitted Original manuscript
12 Nov 2010 Author responded Author comments - Alan Wade
Resubmission - Version 2
12 Nov 2010 Submitted Manuscript version 2
2 Dec 2010 Reviewed Reviewer Report - Thomas Schlaepfer
6 Jan 2011 Reviewed Reviewer Report - Paul Walters
10 Feb 2011 Author responded Author comments - Alan Wade
Resubmission - Version 3
10 Feb 2011 Submitted Manuscript version 3
17 Feb 2011 Reviewed Reviewer Report - Thomas Schlaepfer
17 Feb 2011 Reviewed Reviewer Report - Paul Walters
21 Feb 2011 Author responded Author comments - Alan Wade
Resubmission - Version 4
21 Feb 2011 Submitted Manuscript version 4
1 Mar 2011 Author responded Author comments - Alan Wade
Resubmission - Version 5
1 Mar 2011 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
4 Mar 2011 Author responded Author comments - Alan Wade
Resubmission - Version 7
4 Mar 2011 Submitted Manuscript version 7
9 Mar 2011 Author responded Author comments - Alan Wade
Resubmission - Version 8
9 Mar 2011 Submitted Manuscript version 8
Publishing
16 Mar 2011 Editorially accepted
16 Mar 2011 Article published 10.1186/1471-244X-11-42

You can find further information about peer review here.

Back to article page